M. Sawaki

发表

Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure.

D. Fukai, M. Kinoshita, T. Tsutamoto, 1998, Journal of the American College of Cardiology.

High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure.

M. Kinoshita, M. Fujii, T. Tsutamoto, 2000, Journal of the American College of Cardiology.

Heart Failure Relationship Between Endothelin-1 Extraction in the Peripheral Circulation and Systemic Vascular Resistance in Patients With Severe Congestive Heart Failure

M. Kinoshita, M. Fujii, T. Tsutamoto, 2016 .

Angiotensin II type 1 receptor antagonist decreases plasma levels of tumor necrosis factor alpha, interleukin-6 and soluble adhesion molecules in patients with chronic heart failure.

M. Kinoshita, M. Fujii, T. Tsutamoto, 2000, Journal of the American College of Cardiology.

Plasma brain natriuretic peptide level as a biochemical marker of morbidity and mortality in patients with asymptomatic or minimally symptomatic left ventricular dysfunction. Comparison with plasma angiotensin II and endothelin-1.

M. Kinoshita, Y. Sugimoto, M. Fujii, 1999, European heart journal.

Relationship between endothelin-1 extraction in the peripheral circulation and systemic vascular resistance in patients with severe congestive heart failure.

M. Kinoshita, M. Fujii, T. Tsutamoto, 1999, Journal of the American College of Cardiology.

Effects of a specific endothelin-converting enzyme inhibitor on cardiac, renal, and neurohumoral functions in congestive heart failure: comparison of effects with those of endothelin A receptor antagonism.

D. Fukai, M. Kinoshita, T. Tsutamoto, 1999, Circulation.

Increased von Willebrand Factor in the Endocardium as a Local Predisposing Factor for Thrombogenesis in Overloaded Human Atrial Appendage

M. Kinoshita, M. Fujii, T. Tsutamoto, 2016 .

Absolute, not relative, changes are important when interpreting trial data: Reply

M. Kinoshita, M. Fujii, T. Tsutamoto, 2001 .

Dilated Cardiomyopathy Relationship Between Tumor Necrosis Factor-Alpha Production and Oxidative Stress in the Failing Hearts of Patients With Dilated Cardiomyopathy

M. Kinoshita, Y. Sugimoto, Takashi Yamamoto, 2016 .

Relationship between tumor necrosis factor-alpha production and oxidative stress in the failing hearts of patients with dilated cardiomyopathy.

M. Kinoshita, Y. Sugimoto, Takashi Yamamoto, 2001, Journal of the American College of Cardiology.

Chronic effects of a novel, orally active endothelin receptor antagonist, T-0201, in dogs with congestive heart failure.

D. Fukai, M. Kinoshita, T. Tsutamoto, 1998, Journal of cardiovascular pharmacology.

Transcardiac extraction of circulating endothelin-1 across the failing heart.

M. Kinoshita, Y. Sugimoto, M. Fujii, 2000, The American journal of cardiology.

Significant roles of endothelin-A- and -B-receptors in renal function in congestive heart failure.

M. Kinoshita, M. Fujii, T. Tsutamoto, 2000, Journal of cardiovascular pharmacology.

Chronic effects of an orally active selective endothelin-B-receptor antagonist in experimental congestive heart failure.

M. Kinoshita, M. Fujii, T. Tsutamoto, 2000, Journal of cardiovascular pharmacology.

Effect of spironolactone on plasma brain natriuretic peptide and left ventricular remodeling in patients with congestive heart failure.

M. Kinoshita, M. Fujii, T. Tsutamoto, 2001, Journal of the American College of Cardiology.

Spironolactone inhibits the transcardiac extraction of aldosterone in patients with congestive heart failure.

M. Kinoshita, Y. Sugimoto, M. Fujii, 2000, Journal of the American College of Cardiology.

Endothelin-1 promotes vascular structural remodeling during the progression of heart failure prevention of vascular remodeling using a specific endothelin-converting enzyme inhibitor.

K. Kurokawa, M. Kinoshita, T. Yamamoto, 2001, Life sciences.